1. Neurostimulation is often associated with use in pain relief or therapy.
2. Neurostimulation is naturally segmented into two classifications — the devices that use external electrodes and those that use internal, or implanted, electrodes.
3. The two common external electrode methods are electromuscular stimulation and transcutaneous electrical nerve stimulation. Spinal cord stimulation and vagus nerve stimulation rely on implanted electrodes.
4. The global neurostimulation device market includes a number of individual market segments such as deep brain stimulation, sacral nerve stimulation and spinal cord stimulation.
5. Key players in the market include Boston Scientific, Cochlear, Cyberonics, St. Jude Medical and Medtronic.
More articles on devices:
OrthAlign grew 46% in 2014 — 5 things to know
Medtronic-Covidien deal final — but how will it change the industry? 7 thoughts
OSU Wexner Medical Center physicians 1st to implant plastic device for cartilage damage
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
